{"id":"W4407762963","doi":"10.1016/j.ijgc.2025.101700","title":"Pembrolizumab Or Placebo Plus Adjuvant Chemotherapy With Or Without Radiotherapy In Patients With Newly Diagnosed, High-Risk Endometrial Cancer: Exploratory Analysis Of Disease-Specific Survival From The Phase 3 ENGOT-En11/GOG-3053/KEYNOTE-B21 Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh; University of Texas MD Anderson Cancer Center; University of California, San Diego; National and Kapodistrian University of Athens; McGovern Medical School","keywords":"Medicine; Endometrial cancer; Pembrolizumab; Oncology; Placebo; Internal medicine; Radiation therapy; Adjuvant; Chemotherapy; Disease; Cancer; Immunotherapy; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002184914,0.0008415952,0.002189876,0.0003035988,0.0002471952,0.0008080405,0.0005430218,0.0007777335,0.001618037],"category_scores_gemma":[0.001456697,0.0003463581,0.002767677,0.0003893117,0.0005013635,0.0009848216,0.0003399286,0.001985922,0.0002526825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006671116,"about_ca_system_score_gemma":0.0007807558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009592697,"about_ca_topic_score_gemma":0.003575633,"domain_scores_codex":[0.9993179,0.0003963235,0.00003151725,0.0001077868,0.0000393892,0.0001070013],"domain_scores_gemma":[0.9993338,0.0002779588,0.000154061,0.00005951187,0.0000238564,0.000150806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9213895,0.003710825,0.01321543,0.00078425,0.005734078,0.00008123017,0.00008596175,0.001661639,0.005416341,0.0001309383,0.0009686564,0.04682118],"study_design_scores_gemma":[0.5446971,0.2720798,0.1557909,0.0002905606,0.0162035,0.0002661571,0.0002475128,0.003443376,0.001954181,0.0007942451,0.00415687,0.00007585381],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904772,0.007173842,0.0002484139,0.0002693346,0.00009376262,0.0002267557,0.0006719041,0.00001876156,0.0008199656],"genre_scores_gemma":[0.9956191,0.002000508,0.0002940215,0.0003388753,0.0001055822,0.0002064332,0.0008812505,0.000007964453,0.0005462375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002189876,"threshold_uncertainty_score":0.01155508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03192864934198134,"score_gpt":0.3391723876426938,"score_spread":0.3072437383007125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}